D M Kerins, R Murray, G A FitzGerald. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Adenylyl Cyclases/metabolismAdultAlprostadil/pharmacologyAlprostadil/physiologyAlprostadil/therapeutic useAnimalsBlood Platelets/drug effectsBlood Platelets/metabolismCoronary Disease/drug therapyDouble-Blind MethodDrug EvaluationDrug ToleranceDuctus Arteriosus/drug effectsEnzyme Activation/drug effectsEpoprostenol/pharmacologyEpoprostenol/physiologyEpoprostenol/therapeutic useExtracorporeal Circulation/adverse effectsHeart Defects, Congenital/drug therapyHeart Failure/drug therapyHumansHypertension, Pulmonary/drug therapyInfantInfant, NewbornPlatelet Aggregation/drug effectsRaynaud Disease/drug therapyReceptors, EpoprostenolReceptors, Prostaglandin/metabolismReceptors, Prostaglandin ERenal Dialysis/adverse effectsSecond Messenger SystemsThrombocytopenia/etiologyThrombocytopenia/prevention & controlVascular Diseases/drug therapy
Substances: See more » Receptors, EpoprostenolReceptors, ProstaglandinReceptors, Prostaglandin EEpoprostenolAdenylyl CyclasesAlprostadil
Year: 1991 PMID: 1848945
Source DB: PubMed Journal: Prog Hemost Thromb ISSN: 0362-6350